Publication related to RSI or an RSI staff member

Using data on the uncertainty of LOAELs to model the probability of observing adverse effects in low-dose studies of the toxicity of chemical mixtures.

Authors

  • Price, Paul, Price P, Risk Sciences International, 3801 Bluebird Drive. SW, Cedar Rapids, IA, 52404, USA. Electronic address: pprice@risksciences.com.

  • Hagiwara, Shintaro, Hagiwara S, Risk Sciences International, Suite 343, 1505 Laperriere Avenue, Ottawa, ON, K1Z 7T1, Canada.

  • Momoli, Franco, Momoli F, Risk Sciences International, Suite 343, 1505 Laperriere Avenue, Ottawa, ON, K1Z 7T1, Canada.

YEAR OF PUBLICATION: 2025
SOURCE: Regul Toxicol Pharmacol. 2025 Sep;161:105843. doi: 10.1016/j.yrtph.2025.105843. Epub 2025 May 5.
JOURNAL TITLE ABBREVIATION: Regul Toxicol Pharmacol
JOURNAL TITLE: Regulatory toxicology and pharmacology : RTP
ISSN: 1096-0295 (Electronic) 0273-2300 (Linking)
VOLUME: 161
PAGES: 105843
PLACE OF PUBLICATION: Netherlands
ABSTRACT:

Studies of chemical mixtures toxicity are often designed to differentiate mixtures that follow dose-addition from those that follow response-addition. One design used for this purpose doses animals at levels below the levels that separately have been shown to cause a detectable occurence of a common effect. Under response addition, no effects are expected to be observed since no chemical would independently cause an observable response at the administered doses. Effects, however, could be observed if some or all of the chemicals follow dose addition. Thus, any observation of response can be taken as evidence of dose addition. A recent publication estimated interstudy variation in chemicals' LOAELs. These estimates are here used to predict the probability of observing an effect in mixtures that follow response- or dose-addition models. Two case studies are presented. One is on a set of hypothetical mixtures containing from 2 to 20 chemicals. The second is on mixtures of anti-androgenic chemicals. In these studies, LOAEL uncertainty blurred the difference between dose and response models, and for many mixtures, it is not possible to determine whether response or dose additivity occurred. These findings suggest that caution should be taken when using these studies as evidence for dose addition.

COPYRIGHT INFORMATION: Copyright (c) 2025 The Authors. Published by Elsevier Inc. All rights reserved.
LANGUAGE: eng
DATE OF PUBLICATION: 2025 Sep
DATE OF ELECTRONIC PUBLICATION: 20250505
DATE COMPLETED: 20250606
DATE REVISED: 20250606
MESH DATE: 2025/06/07 16:44
EDAT: 2025/05/08 00:25
STATUS: MEDLINE
PUBLICATION STATUS: ppublish
LOCATION IDENTIFIER: S0273-2300(25)00073-X [pii] 10.1016/j.yrtph.2025.105843 [doi]
OWNER: NLM

Related RSI Experts

Paul Price

Senior Analyst

Dr. Paul Price is a Senior Analyst at Risk Sciences International (RSI), bringing over four decades of experience as a pioneer in exposure science and chemical risk assessment. Since joining RSI in 2019, Dr. Price has focused on advancing mixture...
Read More about Paul Price

Shintaro Hagiwara

Risk Analyst, Statistician

Dr. Shintaro Hagiwara is a Risk Analyst and Statistician at Risk Sciences International (RSI), where he contributes cutting-edge statistical insight to risk assessments, particularly in chemical safety. Since joining RSI’s technical team in 2018 and transitioning to a full-time role...
Read More about Shintaro Hagiwara

Franco Momoli

Vice-President Chemical and Product Safety

Dr. Franco Momoli joined Risk Sciences International (RSI) in 2019 and currently serves as Vice-President, Chemical and Product Safety. In this role, he leads a multidisciplinary team of epidemiologists, risk assessors, toxicologists, and biostatisticians in conducting human health risk assessments...
Read More about Franco Momoli